DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ)
$6.74 0.005 (0.0742%)
Analysed DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) News Sources
DiaMedica Therapeutics Inc (DMAC) Q4 2025 Earnings Call Highlights: Strong Cash Position and ...
31-03-2026
yahoo.com
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
07-04-2026
yahoo.com
DiaMedica Therapeutics Highlights DM199 Preeclampsia Data, Stroke Interim Catalyst at RedChip Conference
16-04-2026
marketbeat.com
RedChip's Biotech Virtual Investor Conference Replays Now Available
21-04-2026
yahoo.com
DiaMedica Therapeutics Q1 Earnings Call Highlights
07-05-2026
marketbeat.com
DiaMedica Therapeutics (NASDAQ:DMAC) Is In A Good Position To Deliver On Growth Plans
10-05-2026
yahoo.com
DiaMedica (DMAC) Q4 2025 Earnings Transcript
01-06-2026
fool.com
DiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program
16-06-2026
yahoo.com
DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction
23-06-2026
yahoo.com
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17-07-2026
yahoo.com
What is the current price of DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ)?
The current price of DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) is $6.74.
DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) absolute price change since previous trading day?
The absolute price change of DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) since the previous trading day is $0.005.
DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) percentage price change since previous trading day?
The percentage price change of DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) since the previous trading day is 0.0742%.
What is the most recent average sentiment score for DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ)?
The most recent average sentiment score for DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ)?
The most recent sentiment for DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) is .
SEC-8K** Filing Available For DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.